RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 81 filers reported holding RELMADA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $81 | +22.7% | 27 | 0.0% | 0.00% | – |
| Q2 2023 | $66 | -48.0% | 27 | -51.8% | 0.00% | – |
| Q1 2023 | $127 | -95.8% | 56 | -92.8% | 0.00% | – |
| Q4 2022 | $3,000 | -98.6% | 777 | -86.2% | 0.00% | – |
| Q3 2022 | $208,000 | +128.6% | 5,627 | +17.8% | 0.00% | – |
| Q2 2022 | $91,000 | +15.2% | 4,777 | +64.6% | 0.00% | – |
| Q1 2022 | $79,000 | +2533.3% | 2,902 | +2745.1% | 0.00% | – |
| Q4 2021 | $3,000 | -85.7% | 102 | -87.4% | 0.00% | – |
| Q3 2021 | $21,000 | +23.5% | 809 | +54.7% | 0.00% | – |
| Q2 2021 | $17,000 | +41.7% | 523 | +60.9% | 0.00% | – |
| Q1 2021 | $12,000 | +20.0% | 325 | 0.0% | 0.00% | – |
| Q4 2020 | $10,000 | -16.7% | 325 | 0.0% | 0.00% | – |
| Q3 2020 | $12,000 | +300.0% | 325 | +333.3% | 0.00% | – |
| Q2 2020 | $3,000 | 0.0% | 75 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | – | 75 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Guild Investment Management, Inc. | 205,300 | $615,900 | 1.03% |
| Deep Track Capital, LP | 2,837,818 | $8,513,454 | 0.33% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 974,082 | $2,922,246 | 0.23% |
| apricus wealth, LLC | 77,362 | $239,822 | 0.21% |
| Palo Alto Investors LP | 732,400 | $2,197,200 | 0.21% |
| RTW INVESTMENTS, LP | 2,131,835 | $6,395,505 | 0.14% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $300,000 | 0.09% |
| AdvisorShares Investments LLC | 112,908 | $338,724 | 0.09% |
| Savior LLC | 3,500 | $10,500 | 0.07% |
| Spotlight Asset Group, Inc. | 20,000 | $60,000 | 0.05% |